Literature DB >> 10579478

Multiple-dose pharmacokinetics of rectally administered acetaminophen in term infants.

R A van Lingen1, H T Deinum, C M Quak, A Okken, D Tibboel.   

Abstract

OBJECTIVE: To investigate pharmacokinetics and pharmacodynamics of rectally administered acetaminophen (INN, paracetamol) in term neonates directly after birth.
METHODS: In this prospective clinical trial, term neonates wtih painful conditions or who were undergoing painful procedures received multiple-dose acetaminophen. Serum concentrations were determined serially with an HPLC method, and pharmacokinetic analysis was performed. Pain assessment was performed by means of a validated pain score.
RESULTS: Ten consecutive term neonates received four rectal doses of acetaminophen, 20 mg/kg body weight, every 6 hours. Mean peak serum concentrations (+/-SD) during multiple-dose administration were 10.79 +/- 6.39 mg/L, 15.34 +/- 5.21 mg/L, and 6.24 +/- 3.64 mg/L for the entire group, boys, and girls, respectively. There was a significant difference between the boys and the girls (P = .01). No serum concentrations associated with toxicity (>120 mg/L) were found. Median time to peak serum concentration was 1.5 hours after the first dose and 15 hours for multiple doses. Mean (+/-SD) half-life was 2.7 +/- 1.4 hours in eight patients. There was no correlation between dose and serum concentration or between pain score and serum concentration. There was a significant inverse relationship between the preceding pain score and peak serum concentrations.
CONCLUSIONS: In term neonates, multiple rectal doses of acetaminophen, 20 mg/kg body weight, led to widely varying serum concentrations but did not result in therapeutic concentrations in all infants. Boys had higher peak concentrations. Because accumulation was not found, a dose of 30 mg/kg followed by doses of 20 mg/kg at 6- to 8-hour administration intervals are appropriate to reach therapeutic concentrations. A concentration-effect relationship could not be determined.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10579478     DOI: 10.1016/S0009-9236(99)70014-7

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  8 in total

Review 1.  Pharmacological therapy for analgesia and sedation in the newborn.

Authors:  K J S Anand; R W Hall
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-11       Impact factor: 5.747

2.  Neonatal pharmacology: extensive interindividual variability despite limited size.

Authors:  Cuneyt Tayman; Maisa Rayyan; Karel Allegaert
Journal:  J Pediatr Pharmacol Ther       Date:  2011-07

Review 3.  Pain management in newborns.

Authors:  Richard W Hall; Kanwaljeet J S Anand
Journal:  Clin Perinatol       Date:  2014-10-07       Impact factor: 3.430

Review 4.  Nonsteroidal anti-inflammatory agents in neonates.

Authors:  John L Morris; David A Rosen; Kathleen R Rosen
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

5.  Evaluation of changes in oral drug absorption in preterm and term neonates for Biopharmaceutics Classification System (BCS) class I and II compounds.

Authors:  Amit A Somani; Kirstin Thelen; Songmao Zheng; Mirjam N Trame; Katrin Coboeken; Michaela Meyer; Katrin Schnizler; Ibrahim Ince; Stefan Willmann; Stephan Schmidt
Journal:  Br J Clin Pharmacol       Date:  2015-10-30       Impact factor: 4.335

6.  Pharmacokinetics of single dose intravenous propacetamol in neonates: effect of gestational age.

Authors:  K Allegaert; C D Van der Marel; A Debeer; M A L Pluim; R A Van Lingen; C Vanhole; D Tibboel; H Devlieger
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-01       Impact factor: 5.747

7.  Safety of Rectal Administration of Acetaminophen in Neonates.

Authors:  Lori Chen; Monica Zhang; Jason Yung; Jennifer Chen; Carol McNair; Kyong-Soon Lee
Journal:  Can J Hosp Pharm       Date:  2018-12-31

8.  Trial of repeated analgesia with Kangaroo Mother Care (TRAKC Trial).

Authors:  Marsha Campbell-Yeo; Celeste Johnston; Britney Benoit; Margot Latimer; Michael Vincer; Claire-Dominique Walker; David Streiner; Darlene Inglis; Kim Caddell
Journal:  BMC Pediatr       Date:  2013-11-09       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.